A breast cancer drug with the power to slow the progression of the disease has been offering hope to hundreds of women across Scotland, yet patients in England and Wales have been denied the treatment Get the latest top news stories sent straight to your inbox with our daily newsletter We have more newsletters Get the latest top news stories sent straight to your inbox with our daily newsletter We have more newsletters Scottish Breast Cancer patients are being offered a potentially life-saving drug that can cut the risk of advanced breast cancer spreading by more than a third, despite both NHS England and Wales choosing to block the drug. The game-changing drug, Enhertu is approved for use in HER2-low breast cancer patients in both Scotland and Northern Ireland, but in a controversial move, the National Institute for Health and Care Excellence (NICE) has blocked its use in England, with women in Wales also being denied the life-prolonging medication. Compelling evidence suggests that treatment with the drug, whose full name is, trastuzumab deruxtecan can actually increase the amount of time patients can live and ultimately give them more time before their disease progresses, reports The Guardian.
In fact, earlier this week new data from the world’s largest cancer conference revealed “really exciting” news about Enhertu, when scientists revealed that it may actually be even more effective than previously thought. Sharing the results of their recent trial data, medics exp.
